Suppr
超能文献

ASO Author Reflections: The Evolving Role of Immunotherapy for Gastro-Esophageal Malignancies.

作者信息

Emiloju Oluwadunni, Miao Ruoyu, Alese Olatunji

机构信息

Winship Cancer Institute of Emory University, Atlanta, GA, USA.

出版信息

Ann Surg Oncol. 2025 May 22. doi: 10.1245/s10434-025-17493-5.

DOI:10.1245/s10434-025-17493-5

PMID:40402421

Abstract

摘要

相似文献

ASO Author Reflections: The Evolving Role of Immunotherapy for Gastro-Esophageal Malignancies.

Ann Surg Oncol. 2025 May 22. doi: 10.1245/s10434-025-17493-5.

ASO Author Reflections: Superior Postoperative Outcomes from Completely Minimally Invasive Approach Versus Hybrid Approach to Esophagectomy for Esophageal and Gastro-Esophageal Junctional Cancer.

Ann Surg Oncol. 2020 Dec;27(Suppl 3):828-829. doi: 10.1245/s10434-020-08838-3. Epub 2020 Jul 10.

ASO Author Reflections: The Evolving Evidence of Prehabilitation in Frail Cancer Patients Undergoing Surgery.

Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17670-6.

ASO Author Reflections: The Impact of Adjuvant Therapy in the Era of Neoadjuvant Strategies for Pancreatic Cancer.

Ann Surg Oncol. 2025 Jul 5. doi: 10.1245/s10434-025-17788-7.

ASO Author Reflections: Novel 2D Histopathological Markers for the Risk Stratification of Sentinel Node Metastasis in the Era of Adjuvant Systemic Therapy for Primary Cutaneous Melanoma.

Ann Surg Oncol. 2025 Sep;32(9):6938-6939. doi: 10.1245/s10434-025-17610-4. Epub 2025 Jun 19.

ASO Author Reflections: Postoperative Recurrence of Clinical Stage I Esophageal Cancer: a Call for Optimal Postoperative Follow-Up.

Ann Surg Oncol. 2025 Sep;32(9):6445-6446. doi: 10.1245/s10434-025-17666-2. Epub 2025 Jun 14.

The Evolving Role of Immunotherapy for Gastroesophageal Malignancies.

Ann Surg Oncol. 2025 May 7. doi: 10.1245/s10434-025-17386-7.

ASO Author Reflections: Rethinking Tumor Regression Grade as a Prognostic Marker in Esophageal Adenocarcinoma: The Importance of Treatment Context.

Ann Surg Oncol. 2025 May 28. doi: 10.1245/s10434-025-17447-x.

ASO Author Reflections: Intratumoral Lipopolysaccharide as a Novel Biomarker of the Tumor Microenvironment and Prognosis in Esophageal Squamous Cell Carcinoma.

Ann Surg Oncol. 2025 Jul 18. doi: 10.1245/s10434-025-17919-0.

ASO Author Reflections: Tumor Location and TRG in Neoadjuvant Immunotherapy for Esophageal Cancer.

Ann Surg Oncol. 2025 Apr 20. doi: 10.1245/s10434-025-17309-6.

本文引用的文献

The Evolving Role of Immunotherapy for Gastroesophageal Malignancies.

Ann Surg Oncol. 2025 May 7. doi: 10.1245/s10434-025-17386-7.

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO.

Ann Oncol. 2025 Mar;36(3):285-296. doi: 10.1016/j.annonc.2024.11.016. Epub 2024 Dec 3.

Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.

J Clin Oncol. 2024 Feb 1;42(4):410-420. doi: 10.1200/JCO.23.00975. Epub 2023 Nov 14.

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.

J Clin Oncol. 2023 Jan 10;41(2):255-265. doi: 10.1200/JCO.22.00686. Epub 2022 Aug 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

ASO Author Reflections: The Evolving Role of Immunotherapy for Gastro-Esophageal Malignancies.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译